Dr. John David Christein, MD

Dr. Christein practices at Birmingham Hematology Oncology Assoc in Mountain Brk, Alabama.

Dr. Christein's NPI, 1508809328, was assigned on June 13, 2006. Dr. Christein graduated from Rush Medical College of Rush University in 1998. Dr. Christein holds Alabama license 26740.

Dr. Christein's primary practice is Birmingham Hematology Oncology Assoc, at 500 Office Park Dr, Mountain Brk, AL 35223 in Jefferson County. The practice phone is (205) 870-4783.

Dr. Christein's primary practice is Birmingham Hematology Oncology Assoc in Mountain Brk, Alabama. Dr. Christein is also affiliated with UAB Hospital. The medical group on file is UAB Medicine. Dmand AI also links Dr. Christein to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Christein practices, 4 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Christein's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Christein is licensed in Alabama.

CMS data shows 374 Medicare services from Dr. Christein across 11 procedure codes in 2024, for 148 Medicare patients. Medicare paid $43,436 for them.

CMS counts 148 Medicare patients who saw Dr. Christein in 2024. The largest group is 65 to 74, with 65 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Christein's median patient age at 67, with 53% women.

In 2024, Dr. Christein wrote 164 Medicare Part D claims for 61 patients. 82% of them were for generic drugs. CMS names the drug for 80 of them, across 5 drugs with 11 or more claims each, at $50,961 in total drug cost. In 2023, CMS named 94 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Christein for performance year 2024, reported as part of a group. Dr. Christein accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

Hernia repair - groin (open): 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 56 papers to Dr. Christein, published from 2010 to 2024. 2014 was the busiest year, with 5. The most frequent topics are Pancreaticoduodenectomy, Postoperative Complications and Pancreatic Fistula. Dr. Christein has published most often in Ann Surg. Dr. Christein's most frequent co-authors are Stephen W. Behrman, MD, Mark P. Callery, MD and Jeffrey A. Drebin, MD.

CMS Open Payments shows 65 general payments to Dr. Christein from 26 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. Boston Scientific Corporation paid the most, $472.

Dr. Christein graduated from Rush Medical College of Rush University in 1998.